| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |